In vitro activity of BAL9141 against clinical isolates of gram-negative bacteria
- 1 January 2004
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 48 (1) , 73-75
- https://doi.org/10.1016/j.diagmicrobio.2003.09.006
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- In Vitro Activity of S-3578, a New Broad-Spectrum Cephalosporin Active against Methicillin-Resistant StaphylococciAntimicrobial Agents and Chemotherapy, 2003
- RWJ-54428 (MC-02,479), a New Cephalosporin with High Affinity for Penicillin-Binding Proteins, Including PBP 2a, and Stability to Staphylococcal Beta-LactamasesAntimicrobial Agents and Chemotherapy, 2003
- In vitro evaluation of BAL9141, a novel parenteral cephalosporin active against oxacillin-resistant staphylococciJournal of Antimicrobial Chemotherapy, 2002
- In vitro activity of a new cephalosporin, RWJ-54428, against streptococci, enterococci and staphylococci, including glycopeptide-intermediate Staphylococcus aureus.Journal of Antimicrobial Chemotherapy, 2002
- BAL 9141, a new broad-spectrum pyrrolidinone cephalosporin: activity against clinically significant anaerobes in comparison with 10 other antimicrobialsJournal of Antimicrobial Chemotherapy, 2002
- BAL9141, a Novel Extended-Spectrum Cephalosporin Active against Methicillin-Resistant Staphylococcus aureus in Treatment of Experimental EndocarditisAntimicrobial Agents and Chemotherapy, 2002
- In Vitro Activities of RWJ-54428 (MC-02,479) against Multiresistant Gram-Positive BacteriaAntimicrobial Agents and Chemotherapy, 2001
- In Vitro and In Vivo Properties of Ro 63-9141, a Novel Broad-Spectrum Cephalosporin with Activity against Methicillin-Resistant StaphylococciAntimicrobial Agents and Chemotherapy, 2001